166 related articles for article (PubMed ID: 27163775)
21. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
[TBL] [Abstract][Full Text] [Related]
22. Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons.
Daniels JR; Wessinger WD; Hardwick WC; Li M; Gunnell MG; Hall CJ; Owens SM; McMillan DE
Psychopharmacology (Berl); 2006 Mar; 185(1):36-44. PubMed ID: 16479372
[TBL] [Abstract][Full Text] [Related]
23. Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE.
Stevens MW; Rüedi-Bettschen D; Gunnell MG; Tawney R; West CM; Owens SM
Drug Alcohol Depend; 2019 Nov; 204():107484. PubMed ID: 31521953
[TBL] [Abstract][Full Text] [Related]
24. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
Hay CE; Ewing LE; Hambuchen MD; Zintner SM; Small JC; Bolden CT; Fantegrossi WE; Margaritis P; Owens SM; Peterson EC
J Pharmacol Exp Ther; 2020 Jul; 374(1):16-23. PubMed ID: 32245884
[TBL] [Abstract][Full Text] [Related]
25. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
26. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
27. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
[TBL] [Abstract][Full Text] [Related]
28. Effects of methamphetamine isomers on d-methamphetamine self-administration and food-maintained responding in male rats.
Bardo MT; Denehy ED; Hammerslag LR; Dwoskin LP; Blough BE; Landavazo A; Bergman J; Kohut SJ
Psychopharmacology (Berl); 2019 Dec; 236(12):3557-3565. PubMed ID: 31346628
[TBL] [Abstract][Full Text] [Related]
29. Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats.
Richards JB; Sabol KE; de Wit H
Psychopharmacology (Berl); 1999 Oct; 146(4):432-9. PubMed ID: 10550493
[TBL] [Abstract][Full Text] [Related]
30. Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine.
Peterson EC; Laurenzana EM; Atchley WT; Hendrickson HP; Owens SM
J Pharmacol Exp Ther; 2008 Apr; 325(1):124-33. PubMed ID: 18192498
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological effects of methamphetamine and alpha-PVP vapor and injection.
Marusich JA; Lefever TW; Blough BE; Thomas BF; Wiley JL
Neurotoxicology; 2016 Jul; 55():83-91. PubMed ID: 27237056
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats.
Byrnes-Blake KA; Laurenzana EM; Carroll FI; Abraham P; Gentry WB; Landes RD; Owens SM
Eur J Pharmacol; 2003 Feb; 461(2-3):119-28. PubMed ID: 12586207
[TBL] [Abstract][Full Text] [Related]
33. Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat.
McMillan DE; Hardwick WC; Li M; Gunnell MG; Carroll FI; Abraham P; Owens SM
J Pharmacol Exp Ther; 2004 Jun; 309(3):1248-55. PubMed ID: 14993256
[TBL] [Abstract][Full Text] [Related]
34. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
35. Ca2+ oscillations in response to methamphetamine in dopamine neurons of the ventral tegmental area in rats subchronically treated with this drug.
Uramura K; Yada T; Muroya S; Takigawa M
Ann N Y Acad Sci; 2000 Sep; 914():316-22. PubMed ID: 11085332
[TBL] [Abstract][Full Text] [Related]
36. Age-dependent effects of repeated methamphetamine exposure on locomotor activity and attentional function in rats.
Nazari A; Perez-Fernandez C; Flores P; Moreno M; Sánchez-Santed F
Pharmacol Biochem Behav; 2020 Apr; 191():172879. PubMed ID: 32088359
[TBL] [Abstract][Full Text] [Related]
37. Detrimental effects of self-administered methamphetamine during pregnancy on offspring development in the rat.
Rüedi-Bettschen D; Platt DM
Drug Alcohol Depend; 2017 Aug; 177():171-177. PubMed ID: 28600929
[TBL] [Abstract][Full Text] [Related]
38. Effect of acute and chronic administration of methamphetamine on calcium-calmodulin dependent protein kinase II activity in the rat brain.
Akiyama K; Suemaru J
Ann N Y Acad Sci; 2000 Sep; 914():263-74. PubMed ID: 11085326
[TBL] [Abstract][Full Text] [Related]
39. PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
Reichard EE; Nanaware-Kharade N; Gonzalez GA; Thakkar S; Owens SM; Peterson EC
Pharm Res; 2016 Dec; 33(12):2954-2966. PubMed ID: 27620175
[TBL] [Abstract][Full Text] [Related]
40. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.
Szumlinski KK; Balogun MY; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2000 Aug; 151(2-3):234-41. PubMed ID: 10972470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
